Science 37 is a modern clinical research site that delivers trials directly to patients’ homes.
With nationwide reach and medical licensure across all 50 states, Science 37's Direct-to-Patient Site enables sponsors to expand access, improve retention, and enroll more representative patient populations compared to relying solely on a traditional site-based approach.
Science 37 operates under a single Form FDA 1572 and a central IRB, supported by centralized medical oversight, research-grade nursing, and specialized direct-to-patient clinical operations. The company has successfully completed multiple FDA inspections, resulting in FDA approvals, achieving No Action Indicated (NAI) classifications with zero Form 483 observations.
With more than a decade of experience, Science 37 has supported over 200 clinical trials across Phases I–IV and observational studies. Its model consistently delivers strong performance, including approximately 86% completion rates and contributing an average of 20–30% of total study enrollment as a single site. These outcomes have been validated by the Tufts Center for the Study of Drug Development (Tufts CSDD).
The First & Only FDA-Inspected Direct-to-Patient Site
The First & Only FDA-Inspected Direct-to-Patient Site
We strive to create a world where innovative therapies are approved faster, and health outcomes are equal and improved for everyone.
Our Mission
We develop a team of world-class clinical researchers to expand patient access for clinical trial sponsors by delivering high-quality innovative solutions that enable patients to discover, qualify for, and participate in research, regardless of location.
Leadership
Experts dedicated to improving patient access in clinical research.
Tyler Van Horn
Chief Executive Officer
Debra Weinstein, MD
Chief Medical Officer
Jeff Richardson
Senior Vice President, Operations
Kelly McKee
Vice President, Strategy & Transformation
Scott Arceri
Vice President, Strategic Solutions
Ashley Covington
Vice President, Finance & Accounting
Ali Wherry
Executive Director, Clinical Operations
Brooke Silva
Director, Nursing Solutions
Industry Recognition & Awards
Top industry intelligence organizations have recognized our commitment to transforming clinical research through patient access and clinical efficiency.
Science 37 was named a Finalist for the 3rd annual Site Innovation Award at SCOPE. The Site Innovation Award recognizes sites and partnerships pioneering new approaches to improve clinical trials.
Science 37 was named a Finalist for the 10th annual Participant Engagement Award at SCOPE. The Participant Engagement Award recognizes innovation and change in how the pharmaceutical industry communicates with participants in the fields of recruitment and retention in clinical trials.
Science 37 was awarded the "Research and Development – Site Innovation" honor in the 2025 Clinical Trials Arena Excellence Awards. Powered by GlobalData’s independent research, the Clinical Trials Arena Excellence Awards celebrate organizations driving meaningful progress across key areas, including R&D, Safety, Diversity, and Social Impact.
Science 37 was named “Company of the Year” in the global decentralized clinical trials industry by Frost & Sullivan. Frost & Sullivan's Best Practices Market Leadership Award is bestowed upon companies that exhibit outstanding performance and visionary approaches in their respective industries.
Science 37 was named the winner of “Clinical Efficiency Innovation” in the 8th annual MedTech Breakthrough Awards program in recognition of its Patient Recruitment solution. MedTech Breakthrough is an autonomous market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.
Science 37 was named the winner of the “Market Leadership Award” in the global decentralized clinical trials industry by Frost & Sullivan. Frost & Sullivan's Best Practices Market Leadership Award is bestowed upon companies that exhibit outstanding performance and visionary approaches in their respective industries.
Science 37 was nominated for the prestigious 2023 Prix Galien USA Awards in the category of "Best Digital Health Solution” in recognition of its Direct-to-Patient Site. The Prix Galien Awards, organized by The Galien Foundation, recognize and celebrate groundbreaking innovations in the life sciences industry that significantly advance human health and well-being.
Science 37 was recognized in the 2023 Gartner Hype Cycle for Life Science Clinical Development, which explores areas of innovation that will enable life sciences organizations to respond to industry challenges and provides valuable input necessary to make informed technology investment decisions.
Science 37 was named the winner in the Telehealth Innovation category at the University of California San Francisco (UCSF) Health Hub Digital Health Awards at the 2022 HLTH conference.
Science 37 was recognized by the Everest Group as a Leader in the Decentralized Clinical Trials (DCT) PEAK Matrix Assessment in 2021, 2022, and 2023. The PEAK Matrix provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets. It classifies them into three categories: Leaders, Major Contenders, and Aspirants.
